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ABSTRACT
Introduction: Undernutrition affects ∼165 million
children globally and contributes up to 45% of all child
deaths. India has the highest proportion of global
undernutrition-related morbidity and mortality. This
protocol describes the planned economic evaluation of
a community-based intervention to improve growth in
children under 2 years of age in two rural districts of
eastern India. The intervention is being evaluated
through a cluster-randomised controlled trial (cRCT,
the CARING trial).
Methods and analysis: A cost-effectiveness and
cost–utility analysis nested within a cRCT will be
conducted from a societal perspective, measuring
programme, provider, household and societal costs.
Programme costs will be collected prospectively
from project accounts using a standardised tool.
These will be supplemented with time sheets and
key informant interviews to inform the allocation of
joint costs. Direct and indirect costs incurred by
providers will be collected using key informant
interviews and time use surveys. Direct and indirect
household costs will be collected prospectively,
using time use and consumption surveys.
Incremental cost-effectiveness ratios (ICERs) will be
calculated for the primary outcome measure, that is,
cases of stunting prevented, and other outcomes
such as cases of wasting prevented, cases of infant
mortality averted, life years saved and disability-
adjusted life years (DALYs) averted. Sensitivity
analyses will be conducted to assess the robustness
of results.
Ethics and dissemination: There is a shortage of
robust evidence regarding the cost-effectiveness of
strategies to improve early child growth. As this
economic evaluation is nested within a large scale,
cRCT, it will contribute to understanding the fiscal
space for investment in early child growth, and the
relative (in)efficiency of prioritising resources to this
intervention over others to prevent stunting in this
and other comparable contexts. The protocol has all
necessary ethical approvals and the findings will be
disseminated within academia and the wider policy
sphere.
Trial registration number: ISRCTN51505201;
pre-results.
BACKGROUND
Burden of child undernutrition
Undernutrition affects an estimated 165
million children globally and contributes to
an estimated 45% of all child deaths world-
wide.1 Stunting, that is, low length-for-age or
height-for-age in young children, is a marker
of chronic undernutrition. It is the result of
multiple determinants, including long-term
consumption of a low-quality diet in combin-
ation with morbidity, infectious diseases and
environmental risks.2–4
Stunting in early childhood is associated
with subsequent adverse consequences,
including poor cognitive and educational
Strengths and limitations of this study
▪ This protocol will contribute to the limited
evidence regarding cost-effective strategies to
improve early child growth.
▪ This replicable protocol can assist in designing
economic evaluations for similar complex public
health interventions.
▪ The study design will contribute to our under-
standing of fiscal space for investments in early
child growth.
▪ The design of the economic evaluation will allow
societal, household and provider costs to be
disaggregated.
▪ Community-based interventions may require pilot-
ing and modification for use in other settings.
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performance, reduced work capacity and lower wages in
adulthood.5 It also contributes to the intergenerational
transmission of poverty.6 It is estimated that individual
productivity losses attributable to undernutrition are
more than 10% of lifetime earnings, and losses to gross
domestic product (GDP) may be as high as 2–3%
(World Bank, 2006). The burden of undernutrition dis-
proportionately affects the most vulnerable populations
in low and middle income countries (LMICs).7 8 The
WHO has set a global target to reduce stunting by 40%
by 2025,9 while the 2014 Global Nutrition Report
emphasises the importance of nutrition as the founda-
tion on which healthy lives, ‘resilient livelihoods’ and
‘thriving economies’ are built.10
Approximately one-third of the world’s stunted chil-
dren live in India. Stunting in India is most prevalent
among the poorest households, Scheduled Tribes
(ST) and Scheduled Caste (SC) communities.11 12 The
Government of India has targeted undernutrition through
the Integrated Child Development Scheme (ICDS) and
the National Rural Health Mission (NRHM). The ICDS
distributes supplementary food to children through a
network of village-based workers known as ‘Anganwadi’
workers. Launched in 2005, the NRHM (now renamed
National Health Mission or NHM) aims to provide
accessible, affordable and quality healthcare services to
the rural population and vulnerable groups.13 Although
ICDS services have nationwide coverage, they mainly
target children aged 3–6 years, by which time many of
the adverse effects of early childhood undernutrition
may already be established.
The Indian Government has recently undertaken
several reforms in the structure of the ICDS. These
include providing supplementary foods to pregnant
women, children under 3 years of age and their mothers
and improving mothers’ feeding and caring practices.
The introduction of an additional community-based
worker to support these efforts is also being considered.
As these reforms are in the earliest stages, evidence on
their likely effect is scarce, as is evidence of their cost-
effectiveness relative to alternative strategies.14–16
CARING trial
CARING is a cluster-randomised controlled trial (cRCT)
located in two districts of Jharkhand and Odisha,
eastern India. The trial aims to assess the effectiveness of
a complex public health intervention that mirrors the
proposed government reforms described above. The
intervention involves recruiting and training a new
community-based health worker engaged in improving
feeding, infection control and caregiving practices for
children under 2 years of age through monthly home
visits to all children under 2. This new community-based
worker also supports monthly women’s groups meetings
working through a ‘undernutrition-focused’ participa-
tory learning and action cycle. The participatory learn-
ing and action cycle involves monthly group meetings
for women. The new community-based health worker
facilitates the meetings and a problem-solving approach
is used to help groups identify community-level health
and nutrition problems, and ﬁnd locally feasible strat-
egies to address the problems identiﬁed.
The trial aims to establish whether the intervention is
effective and cost-effective in reducing stunting in chil-
dren under 2, morbidity and mortality, when compared
with current practice. In all study areas, we also attempt
to strengthen Village Health Sanitation and Nutrition
Committees (VHNSCs) as a common beneﬁt to inter-
vention and control clusters.
The CARING trial is described in detail elsewhere.17
The purpose of this article is to fully describe the meth-
odology for the economic evaluation of the trial.
Economic evaluations of community interventions to
improve children’s growth
Although there is strong evidence demonstrating a signiﬁ-
cant positive contribution of early childhood nutrition
interventions to child survival, growth and development,
existing literature provides little data about the cost-
effectiveness of such interventions.15 The scarcity of
empirical cost-effectiveness data for these interventions is
particularly acute in LMICs.15 18 Policymakers require this
information, in addition to evidence on the efﬁcacy and
effectiveness of programmes, in order to make investment
decisions.
A recent review of the literature on the cost-
effectiveness of early child nutrition interventions identi-
ﬁed six studies from LMICs.15 Two studies examined the
cost-effectiveness of breastfeeding interventions in
Southern Africa;19 a cohort study in KwaZulu-Natal, and
Uganda,20 and a cRCT in Mbale district, South Africa.
Both studies were conducted from the provider per-
spective. Cost-effectiveness ratios were reported as the
cost per mother counselled or cost per visit in
Uganda.20 In South Africa, the total cost of the imple-
mentation was reported, along with the cost per sup-
ported month of exclusive breast feeding and the cost
per additional or increased month of exclusive breast
feeding.19 These ratios are not comparable between the
two trials and the ﬁndings are unlikely to have direct
relevance to the Indian context or to the CARING trial,
which proposes a more comprehensive nutrition
intervention.17
The same literature review also identiﬁed four trials
that have attempted to improve the nutritional status of
children more broadly;
▸ Awasthi et al21 tested a deworming intervention in a
placebo-controlled trial in India.
▸ Sharieff et al22 modelled the effects of published
home fortiﬁcation and micronutrient supplementa-
tion trials in Pakistan.
▸ Waters et al23 trialled a nutrition education pro-
gramme in a health facility-based cRCT in Peru.
▸ Wilford et al24 modelled the community-based man-
agement of severe acute malnutrition (SAM) in
Malawi.
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In the India and Peru studies, cost-effectiveness ana-
lyses were conducted from the societal perspective. The
India and Peru studies reported incremental cost-
effectiveness ratios (ICERs) per case of stunting averted
of $34.67i and $55.16, respectively. The Peru study
reported the cost per death averted at $1952. In Pakistan
and Malawi, cost-effectiveness analyses were conducted
from the provider perspective and as such their ﬁndings
cannot be compared directly with the other two studies.
They did, however, report a cost per disability-adjusted
life year (DALY) averted of $12.20 and $42, respectively,
which can then be compared with other ‘DALY averting’
interventions. In addition, the Pakistan study reported a
cost per death averted of $406.
The proposed economic valuation of the CARING
trial will be the ﬁrst to assess the cost-effectiveness of
combining participatory women’s groups with home
visits to reduce stunting. This economic evaluation will
also employ a societal perspective, thus adding signiﬁ-
cantly to our understanding of the cost-effectiveness of
this intervention and the likely ﬁscal space needed for
its wider implementation. ICERs will be reported for
cases of stunting averted, deaths averted and DALYs
averted, in order to maximise comparability with other
trials and ensure the usefulness of the economic evalu-
ation as a resource allocation tool.
Aim and objectives
The aim of the CARING economic evaluation is to
measure the cost-effectiveness of a community interven-
tion that includes participatory learning and action with
women’s groups and home visits to improve the growth of
children under 2. Activities to strengthen local VHSNCs
will be undertaken in intervention and control arms.
The speciﬁc objectives of the economic evaluation
are:
1. To measure the costs of setting up and implementing
the community intervention to improve children’s
growth and the strengthening of VHSNCs.
2. To estimate the costs to the health system, of (a) treat-
ment for SAM provided at Malnutrition Treatment
Centres (MTCs) or Nutritional Rehabilitation Centres
(NRCs); (b) increased care seeking at Primary Health
Centres for childhood illnesses, as a result of the
programme.
3. To measure the direct and indirect cost of the inter-
vention to the health system, when existing commu-
nity health workers may take on a greater workload
resulting from the intervention.
4. To measure the direct and indirect cost of the partici-
pation of community leaders or VHSNC members in
participatory meetings or other activities related to
the intervention.
5. To calculate the household costs of care seeking
related to undernutrition and any costs of changing
feeding and caring behaviours, for example, the pos-
sible costs of buying additional/different foods.
6. To estimate the incremental cost-effectiveness of
the intervention combined with strengthening of
VHSNCs, as compared with strengthening VHSNCs
alone, where all new activities are delivered in add-
ition to existing government programmes.
METHODS
Study design
A cost-effectiveness analysis of the CARING trial, a
cluster-randomised trial that compares a community
intervention to improve children’s growth combined
with the strengthening of VHSNCs, with strengthening
VHSNCs only.17 We will estimate the total and incremen-
tal costs of the intervention prospectively from a societal
perspective, measuring programme, provider and house-
hold costs.
Study setting
As described fully in the trial protocol,17 the CARING
trial takes place in West Singhbhum ( Jharkhand state)
and Kendujhar (Odisha state) districts in India. Odisha
and Jharkhand are among the poorest states in India,
with high rates of child mortality and undernutrition,25 26
and female literacy rates below 50%.27 In 2010, under-5
mortality was estimated 61 and 83 per 1000 live births
in rural Jharkhand and Odisha, respectively.28 29 In
Jharkhand over 50% of children are stunted, and in
Odisha over 45% are stunted.25 26 The study districts are
predominantly rural, with a combined total population
of ∼3.3 million.17
Community-based health and nutrition services for
mothers and children in the study villages are provided
by three community workers: an Anganwadi worker
(AWW), an Accredited Social Health Activist (ASHA)
and an Auxiliary Nurse Midwife (ANM). AWWs provide
supplementary nutrition to pregnant women, breastfeed-
ing mothers and children aged 6 months to 6 years.
ASHAs support community members in accessing essen-
tial healthcare services and promote institutional deliver-
ies. ANMs provide services such as childhood
immunisation and essential medicines. Community-
based services are supplemented with care from primary
care centres, MTCs that specialise in the treatment of
SAM and hospitals.
Study population
The CARING trial area includes 120 geographic clusters
of around 1000 population, typically a village and any
nearby hamlets. These clusters were purposively selected
based on their population size. The study participants
are pregnant women identiﬁed in the third trimester of
iThese costs are reported in International Dollars, at 2005 prices.
Although they were not reported in this currency within the original
publications, they were converted to a common currency and base year
by Batura et al40 to facilitate comparison where possible.
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pregnancy and all children born to pregnant women
recruited between 1 October 2013 and 10 February
2015. Mothers and their children are followed up for a
period of 18 months after the birth of the child.
Trial design
In the CARING trial, a total of 120 purposively selected
geographical clusters, with an estimated total population
of 121 531, were randomised to the two trial arms. The
60 clusters in the intervention arm received home visits,
participatory learning and action meetings and support
to VHNSCs as described further below. The 60 clusters
in the control arm received only the support to
VHNSCs. Study participants are pregnant women identi-
ﬁed in the third trimester of pregnancy and their chil-
dren (n=2520). The randomisation, which took place in
July 2013, was stratiﬁed by district and by number of
hamlets per cluster. The trial is ongoing and is due to
ﬁnish in 2016.
In the intervention clusters, a community intervention
to improve children’s growth involving home visits to all
children under 2 and monthly participatory learning
and action meetings with women’s groups, combined
with VHSNC strengthening activities, is being implemen-
ted. In the control clusters, only VHSNC strengthening
is implemented. In the following section, we present a
brief description of the intervention strategies. A full
description of the intervention design within the
CARING trial is described in detail elsewhere.17
Community intervention to improve children’s growth
The community intervention involves a community-
based worker (known as Suposhan Karyakarta or SPK)
carrying out two main activities: (1) undertaking
monthly home visits and (2) facilitating monthly
women’s group meetings. An SPK will visit all pregnant
women at least once during their pregnancy, and all
mothers of children under 2 on a monthly basis, to
counsel mothers on appropriate feeding, infection
control and care giving. She also facilitates a cycle of
monthly women’s groups, where the discussions will
follow a participatory learning and action cycle focused
on maternal health, child health and nutrition. A four
phase ‘participatory learning and action cycle’, adapted
from previous studies,30 will guide the groups to identify
and prioritise maternal and child health and nutrition
problems, decide on locally appropriate solutions, then
implement and evaluate the solutions. These meetings
primarily target pregnant and lactating mothers,
mothers of children under 2 and adolescent girls. In
home visits and women’s group meetings, the SPK uses
a problem-solving approach.
Strengthening Village Health Sanitation and Nutrition
Committees (VHSNCs)
In intervention and control areas, activities are under-
taken to strengthen the capacity of VHSNCs, which are
village-level government-mandated bodies. VHSNCs are
responsible for assessing the health needs of their com-
munity, preparing and implementing village health
plans and monitoring the delivery of local health and
nutrition services. During the study, several participatory
meetings will be held with VHSNCs. These meetings will
primarily aim to sensitise VHSNCs on issues related to
inequity and exclusion in service provision, in addition
to identifying and addressing gaps in health and nutri-
tion services within their community.
Measurement of health outcomes/effectiveness
Primary outcome
The primary outcome of the CARING trial is children’s
length-for-age z-scores.17 The trial was powered to detect
a 0.15 SD difference in LAZ between intervention and
control at the 0.05 signiﬁcance level. A greater sample
size would be required to detect a realistic change in the
prevalence of stunting: our sample size allows us to
detect a 13% reduction in stunting prevalence, which is
an unfeasible effect for a 24 months intervention
without food supplementation. Cost-effectiveness ana-
lyses focusing on cases of stunting averted would be
useful to inform policymakers’ decisions. We therefore
propose to conduct a cost-effectiveness analysis for cases
of stunting averted if there is evidence of impact on the
prevalence of stunting in children at 18 months at the
0.1 signiﬁcance level or below. Using these z-scores, we
will calculate the prevalence of stunting among children
at 18 months and calculate the number of cases of stunt-
ing averted. Cases averted will be calculated as the differ-
ence between the expected and the actual number of
cases using the adjusted OR.
Secondary outcomes
The trial has a number of secondary outcomes
described in detail in the trial protocol.17 Cost-
effectiveness analyses will be conducted for any reduction
in three key secondary outcomes—underweight, wasting
and infant mortality—where a signiﬁcant impact on these
outcomes is observed at the 0.1 level.
ICERs will thus be calculated for wasting, underweight
and infant mortality, if a signiﬁcant effect is observed at
a p value of 0.1 or less. Estimates of life years saved will
be calculated for infant mortality averted by the inter-
vention if a signiﬁcant ﬁnding is observed. Although no
agreed DALY weight currently exists for undernutrition
in any form, expected ‘DALYs averted’ will be modelled
using mortality averted by the intervention if signiﬁcant,
and evidence from the wider literature about morbidity
gains from averting stunting, wasting and underweight
in young children.31
Equity impact
As the gains from such a complex intervention may not
be equitably shared among the target population,
the equity impact of the intervention will be analysed
within the economic evaluation. Primary and secon-
dary outcomes will be decomposed according to the
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socioeconomic status of ‘recipient households’ and the
economic evaluation stratiﬁed accordingly. To account for
the fact that many households in these districts will be
asset or cash poor, a multidimensional poverty score will
be used to deﬁne households’ socioeconomic status.32–34
These stratiﬁed, subgroup analyses may enable us to
further verify the argument by Carrera et al,35 that invest-
ing in the most deprived communities is more cost-
effective than the same investment in less deprived
communities.
Identification, measurement and valuation of resource use
These analyses will measure the cost-effectiveness of the
intervention from a societal perspective. This perspective
is the most comprehensive, taking into account costs
incurred by the programme, implementing agencies or
donors, providers and households.36 This perspective
determines the time horizon of any modelling, the
choice of costs and outcomes to be included in the ana-
lysis, and the measurement and valuation of costs and
consequences of the intervention.37 38 In this section, we
will describe in detail the proposed methods for measur-
ing and valuing programme costs, provider costs and
household costs. Programme costs include those incurred
by the implementing agencies, that is, University College
London, the Public Health Foundation of India (PHFI)
and Ekjut (http://www.ekjutindia.org), a civil society
organisation leading the study. The provider or health
system costs are those incurred by MTCs, Primary Health
Centres, community workers and VHSNCs. The house-
hold or user costs include those incurred by mothers and
their families. Table 1 shows the ﬂow of cost data collec-
tion described further below.
Programme-related costs
We use a step-down costing methodology39 whereby
costs from programme accounts are entered into a custo-
mised tool created in MS Excel. Cost data are entered
regularly into the tool, which is adapted each year to
reﬂect the changing cost structure of the trial at differ-
ent phases of activity. Using a step-down method, the
main worksheets for entering data allocate costs to one
of the following categories: staff, material, capital and
joint costs. Costs are also divided into start-up and imple-
mentation costs, and between intervention, monitoring
and evaluation and research costs. As these data are
ﬁnancial or accounting costs, they are converted to eco-
nomic costs. This means that capital costs are annualised
over their expected useful life, and any donated goods
or volunteer time appearing as a zero costs in account-
ing data—or not appearing in the accounting data in
any form—will be added to the cost sheets and assigned
their current market value.40–42 Key informant interviews
with project leads assist in identifying any donated goods
requiring revaluation and in allocating joint costs
between programme components. The allocation of
joint costs to programme components and activities is
also informed by monthly staff time sheets.
Summary Excel worksheets present the costs by pro-
gramme component such as women’s groups or health
service strengthening. A single summary worksheet also
summarises the total cost data, allows effect data to be
entered and calculates the cost-effectiveness results.
Provider or health system costs
Provider costs or costs to the health system will be calcu-
lated for MTCs, Primary Health Centres, community
workers and VHSNCs.
Malnutrition treatment centres and primary health centres
MTCs provide care for SAM. Demand for these services
may increase if SAM is better identiﬁed in the commu-
nity and/or systems for referring children to MTCs are
improved. Conversely, demand for these services may
decrease if SAM is prevented by improved early child
nutrition.
We will estimate any change in the demand for MTC
services resulting from the intervention, and the con-
comitant value of any additional care provided. The
trial’s routine monitoring forms will capture the number
of children admitted for SAM at MTCs. Differences in
admissions between intervention and control areas will
be attributed to the trial activities. Primary data on the
average unit cost of care for SAM will be collected from
the two MTCs in the project area. A simple cost-capture
form was developed for facility data collection after an
introductory meeting with centre managers. Data from
the cost-capture form will be used to complement exist-
ing data from centre reports, patients’ records and pub-
lished national and state reports relating to MTCs. Costs
of services provided by the MTCs will be calculated
using a step-down approach.39
For Primary Health Centres, any change in demand
for primary care will be identiﬁed in the trial’s routine
monitoring forms as described above. Any cost of that
change in demand will be calculated using published
data on the unit costs of treatment at Primary Health
Centres.43
Community workers
The CARING intervention may increase the workload of
community health workers by increasing demand for
their services. Conversely, the new community-based
worker (or SPK) introduced by the CARING trial,
together with a stronger emphasis on preventive activ-
ities, may decrease the workload of existing community
workers.
Changes in the number of referrals, demand for coun-
selling, uptake of immunisation and presentation for
growth monitoring services will be measured with
routine trial monitoring forms. The value of the change
in demand for these services will be calculated using
process data on the average time spent on each activity,
and publically available data on the salaries paid to
community workers.
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VHSNCs
During the course of the intervention, several participa-
tory meetings will be held with VHSNC members. The
number of meetings, their duration and participation is
being documented by the project. The opportunity cost
of the time spent by the VHSNC members will be mea-
sured as a proportion of their salary where they are paid
a salary—or as a salary equivalent, where they are
working as volunteers.
Household or user costs
CARING may inﬂuence household costs in a number of
ways. Changes in the quantity, variety or quality of food
fed to pregnant women and young children, may
increase household expenditure on food. The interven-
tion may also increase care seeking. The effect on
health spending of this change may be positive or nega-
tive. Increases in care seeking from a very low base may
increase total spending on care. Conversely, a shift from
curative to preventive care seeking may decrease spend-
ing on care. Similarly, improved early child nutrition
that averts severe malnutrition and related illnesses, may
also reduce the need for care seeking. Finally, as the
intervention seeks to change health and nutrition-
related activities, it may also change the allocation of
time to these activities. Participation in women’s group
meetings and in home visits will also have a direct time
‘cost’.
Changes in food expenditure are measured with a com-
prehensive household consumption and expenditure
survey conducted on a random subsample of 300 house-
holds (150 per trial arm). The consumption and
expenditure model is conducted twice for each partici-
pating household, with the two data collection points
1 year apart. This allows the measure of interest to be
the change in expenditure over a 1-year period, with
that change compared between intervention and control
areas.
Changes in health spending are measured with a set
of questions on care seeking collected from all the
mothers recruited in the project. Care seeking data are
also collected at two time points in the trial; ﬁrst when
the pregnant mother is recruited and again when the
baby is 18-month old. In this instance, the measure of
interest is not the change in spending over that time
period, but a comparison of absolute levels of spending
between intervention and control families with children
of the same age.
Finally, the time cost of group participation, participat-
ing in the actions taken by the group, engaging with
home visits or changing health, nutrition or stimulation
behaviours will be measured using a time use survey to
be conducted on a subsample of 120 women, equally
distributed across the intervention and control arms.
Cost-effectiveness analysis
The cost-effectiveness analysis will be conducted as a
within-trial analysis using the intention-to-treat results,
and will be presented in terms of ICERs, calculated as
the arithmetic mean difference in cost between the
Table 1 Steps in cost data collection
Cost category or
perspective
Type of
costs Description Source Sample size
Project/
programme
Direct Costs of implementing the
intervention
Project accounts of
implementing agencies
N/A
Provider/health
system
Direct Costs of referrals made to
MTCs
1. Project records for
number of referrals,
2. MTC costing study for
unit costs of services
All referrals made in intervention
and control clusters
Indirect Opportunity cost of increase
in workload of CHWs
Time use survey with
CHWs
A purposive sample of CHWs in
both arms will be selected for
time use interviews
Opportunity cost of time spent
by VHSNC members in
meetings
Project records All meetings held and number of
people attending the meetings
will be recorded
Patients/
households
Direct Household expenditure on
food
Household consumption
survey
A random subsample of 300
households
Cost of care seeking for
mothers and children
3-month and 18-month
follow-up surveys with
mothers
All participants in the study
Indirect Opportunity cost of
participation in groups and
home visits
Household time use
survey
A random subsample of 120
mothers, with children aged
13–18 months
Opportunity cost of changing
health, nutrition or stimulation
behaviour
Household time use
survey
A random subsample of 120
mothers, with children aged
13–18 months
MTC, Malnutrition Treatment Centres; VHSNC, Village Health Sanitation and Nutrition Committee.
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community intervention combined with VHNSC
strengthening versus VHNSC strengthening only, divided
by the arithmetic mean difference in effect.37 44
ICERs will be calculated for the primary outcome
measure, that is, cases of stunting prevented, and for
selected secondary outcomes and summary measures,
including cases of wasting and underweight prevented,
cases of infant mortality averted, life years saved and
DALYs averted.
A number of sensitivity analyses will be carried out in
order to assess the impact on the cost-effectiveness
results, of changes in variables and parameters with the
greatest uncertainty or with the greatest impact on the
total costs. Cost-effectiveness acceptability curves will be
generated to further describe uncertainty around the
cost estimates.45
Costs will be presented in 2016 prices in Indian
rupees and International Dollars (INT$). All costs will
be adjusted for inﬂation using the Indian Consumer
Price Index (CPI) and will be converted to 2016 INT$
using the 2016 Purchasing Power Parity (PPP) conver-
sion factor for India. Moreover, costs and outcomes will
be converted to present values using an annual discount
rate of 3% in the base case, and annual rates of 0% and
6% in sensitivity analysis.
The affordability of the intervention will be explored
using a range of criteria, including the WHO-CHOICE
criteria,46 together with an analysis of ﬁscal space for
programme delivery using a generalised ﬁscal space
assessment method47 48 and probabilistic analyses to
determine a set of cost-effectiveness thresholds.45 49
These analyses will also enable the exploration of a mul-
ticriteria decision analysis framework for resource alloca-
tion to this and other similar interventions to reduce
stunting and wasting in young children.50 A wide range
of affordability measures have been selected, in part,
due to the paucity of evidence on the cost-effectiveness
of comparable interventions. This precludes the use of
simpler league tables and requires a wider range of
affordability measures against which subsequent analysts
may compare their own ﬁndings.
Conclusion
This paper constitutes the ﬁrst published protocol for
the economic evaluation of a complex public health
intervention to improve child growth. Trial groups are
encouraged to publish protocols in order to improve the
rigour of any subsequent impact assessment. If econo-
mists were encouraged to publish the protocols for
complex economic evaluations in the same way, we may
see a similar rise in the rigour of the conduct of these
studies, along with greater comparability between
ﬁndings.
The proposed analyses aim to assess the cost-
effectiveness of a community intervention to improve
children’s growth. The protocol, which will adhere to
internationally recognised guidelines for conducting
and reporting economic evaluation studies,37 serves to
heighten the transparency of the economic evaluation
and planned analyses. The ﬁndings from this study will
inform policymakers about the relative value for money
of this intervention and the likely ﬁscal space required
to scale up the intervention in three stages; (i) to all
rural populations in Jharkhand and Odisha, (ii) to other
states with a high burden of undernutrition and (iii)
national scale up. This evidence will contribute signiﬁ-
cantly to the scarce evidence regarding the cost-
effectiveness of community interventions in reducing
child undernutrition.
Author affiliations
1University College London, Institute for Global Health, London, UK
2Ekjut, Chakradharpur, Jharkhand, India
3Sitaram Bhartia Institute of Science and Research, New Delhi, India
4Public Health Foundation of India, New Delhi, India
5Department of Public Health and Clinical Medicine, Umeå University, Umeå,
Sweden
6Department of Infection and Population Health, University College London,
London, UK
Twitter Follow Jolene Skordis-Worrall at @JSkordis
Contributors JS-W, HH-B and RS designed the protocol for the Economic
Evaluation and prepared the first draft of the paper. NN, PT and AP
conceived and designed the CARING trial in which this study is embedded.
JS-W, HH-B, NB and A-MP-B designed the cost capture systems and the
processes for allocating and synthesising costs. RS, HH-B, AKO, SS and RG
field tested all data collection forms and substantively contributed to their
design. AKO, SS, NN, PT, HSS, SB, RG, ShiR, SucR, AS, NB, A-MP-B,
AnthC, AndrC, NS and AP all commented on the first draft of the paper and
contributed revisions to the content. All authors have read and approve the
submitted manuscript.
Funding The CARING trial is funded by UK Medical Research Council (MR/
K007270/1), the Wellcome Trust (099708/Z/12/Z) and the Department for
International Development (DfID) under their joint Global Health Trial Scheme.
Competing interests None declared.
Ethics approval The study received ethical approval from the research ethics
committee of the Public Health Foundation of India ( June 2013,
TRC-IEC-163/13), an Independent Ethics Committee linked to Ekjut (May
2013), and University College London’s Research Ethics Committee ( June
2013, reference 1881/002).
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
REFERENCES
1. Black RE, Victora CG, Walker SP, et al. Maternal and child
undernutrition and overweight in low-income and middle-income
countries. Lancet 2013;382:427–51.
2. Semba RD, de Pee S, Sun K, et al. Effect of parental formal
education on risk of child stunting in Indonesia and Bangladesh: a
cross-sectional study. Lancet 2008;371:322–8.
3. Waterlow JC. Introduction. Causes and mechanisms of linear growth
retardation (stunting). Eur J Clin Nutr 1994;48(Suppl 1):S1–4.
4. Allen LH. Nutritional influences on linear growth: a general review.
Eur J Clin Nutr 1994;48(Suppl 1):S75–89.
5. Victora CG, Adair L, Fall C, et al. Maternal and child undernutrition:
consequences for adult health and human capital. Lancet
2008;371:340–57.
Skordis-Worrall J, et al. BMJ Open 2016;6:e012046. doi:10.1136/bmjopen-2016-012046 7
Open Access
group.bmj.com on December 12, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
6. Hertzman C, Wiens M. Child development and long-term outcomes:
a population health perspective and summary of successful
interventions. Soc Sci Med 1996;43:1083–95.
7. Black RE, Allen LH, Bhutta ZA, et al. Maternal and child
undernutrition: global and regional exposures and health
consequences. Lancet 2008;371:243–60.
8. Caulfield LE, de Onis M, Blössner M, et al. Undernutrition as an
underlying cause of child deaths associated with diarrhea,
pneumonia, malaria, and measles. Am J Clin Nutr 2004;80:193–8.
9. de Onis M, Dewey KG, Borghi E, et al. The World Health
Organization’s global target for reducing childhood stunting by 2025:
rationale and proposed actions. Matern Child Nutr 2013;9:6–26.
10. IFPRI. Global nutrition report 2014: actions and accountability to
accelerate the world’s progress on nutrition. Washington DC:
International Food Policy Research Institute, 2014.
11. International Institute for Population Sciences (IIPS) and Macro
International. National Family Health Survey (NFHS-3), 2005–06,
India. Vol 1. Mumbai: IIPS: International Institute for Population
Sciences (IIPS) and Macro International, 2007.
12. The HUNGaMA Survey Report. 2011.
13. NRHM. National Rural Health Mission (NRHM). 2015. http://nrhm.
gov.in/
14. National Advisory Council. Recommendations for a reformed and
strengthened ICDS. 2011 June: http://www.prsindia.org/uploads/
media/Land%20Acquisition/NAC%20press%20release_Land%
20Acq%20and%20others.pdf [Accessed 19th April 2014].
15. Batura N, Hill Z, Haghparast-Bidgoli H, et al. Highlighting the
evidence gap: how cost-effective are interventions to improve early
childhood nutrition and development? Health Policy Plan
2015;30:813–21.
16. Paul VK, Sachdev HS, Mavalankar D, et al. Reproductive health,
and child health and nutrition in India: meeting the challenge. Lancet
2011;377:332–49.
17. Nair N, Tripathy P, Sachdev HS, et al. Participatory women’s groups
and counselling through home visits to improve child growth in rural
eastern India: protocol for a cluster randomised controlled trial. BMC
Public Health 2015;15:384.
18. Gowani S, Yousafzai AK, Armstrong R, et al. Cost effectiveness of
responsive stimulation and nutrition interventions on early child
development outcomes in Pakistan. Ann N Y Acad Sci
2014;1308:149–61.
19. Desmond C, Bland RM, Boyce G, et al. Scaling-up exclusive
breastfeeding support programmes: the example of KwaZulu-Natal.
PLoS ONE 2008;3:e2454.
20. Chola L, Nkonki L, Kankasa C, et al. Cost of individual peer
counselling for the promotion of exclusive breastfeeding in Uganda.
Cost Eff Resour Alloc 2011;9:11.
21. Awasthi S, Pande VK, Fletcher RH. Effectiveness and
cost-effectiveness of albendazole in improving nutritional status of
pre-school children in urban slums. Indian Pediatr 2000;37:19–29.
22. Sharieff W, Horton SE, Zlotkin S. Economic gains of a home
fortification program: evaluation of “Sprinkles” from the provider’s
perspective. Can J Public Health 2006;97:20–3.
23. Waters HR, Penny ME, Creed-Kanashiro HM, et al. The
cost-effectiveness of a child nutrition education programme in Peru.
Health Policy Plan 2006;21:257–64.
24. Wilford R, Golden K, Walker DG. Cost-effectiveness of
community-based management of acute malnutrition in Malawi.
Health Policy Plan 2012;27:127–37.
25. UN World Food Programme (WFP). Food security atlas of rural
Jharkhand. New Delhi, India: Institute for Human Development, 2008.
26. UN World Food Programme (WFP). Food security atlas of rural
Orissa. Institute for Human Development, 2008.
27. Demographic Status of Scheduled Tribe Population of India. 2013
(cited 15 March 2015). Available from: http://tribal.nic.in/Content/
STATISTICSDivision.aspx.
28. Government of India. Annual Health Survey Bulletin 2011–12 Fact
Sheet. Jharkhand. Office of the Registrar General & Census
Commissioner, Ministry of Home Affairs. Government of India, 2012.
29. Government of India. Annual Health Survey Bulletin 2011–12 Fact
Sheet. Odisha. Office of the Registrar General & Census
Commissioner, Ministry of Home Affairs. Government of India, 2012.
30. Prost A, Colbourn T, Seward N, et al. Women’s groups practising
participatory learning and action to improve maternal and newborn
health in low-resource settings: a systematic review and
meta-analysis. Lancet 2013;381:1736–46.
31. Blössner M, de Onis M. Malnutrition: quantifying the health impact at
national and local levels. Geneva: World Health Organization, 2005.
32. Tsui K. Multidimensional poverty indices. Social Choice and Welfare
2002;19:69–93.
33. Alkire S, Foster J. Counting and multidimensional poverty
measurement. J Public Econ 2011;95:476–87.
34. Bourguignon F, Chakravarty SR. The measurement of
multidimensional poverty. J Econ Inequal 2003;1:25–49.
35. Carrera C, Azrack A, Begkoyian G, et al. The comparative
cost-effectiveness of an equity-focused approach to child survival,
health, and nutrition: a modelling approach. Lancet
2012;380:1341–51.
36. Meltzer MI. Introduction to health economics for physicians. Lancet
2001;358:993–8.
37. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the
economic evaluation of health care programmes. 3rd edn Oxford:
Oxford University Press, 2005.
38. Davidoff AJ, Powe NR. The role of perspective in defining economic
measures for the evaluation of medical technology. Int J Technol
Assess Health Care 1996;12:9–21.
39. Conteh L, Walker D. Cost and unit cost calculations using step-down
accounting. Health Policy Plan 2004;19:127–35.
40. Batura N, Pulkki-Brännström AM, Agrawal P, et al. Collecting and
analysing cost data for complex public health trials: reflections on
practice. Glob Health Action 2014;7:23257.
41. Hutton G, Baltussen R. Cost valuation in resource-poor settings.
Health Policy Plan 2005;20:252–9.
42. Walker D. Cost and cost-effectiveness guidelines: which ones to
use? Health Policy Plan 2001;16:113–21.
43. Prinja S, Jeet G, Verma R, et al. Economic analysis of delivering
primary health care services through community health workers in 3
North Indian States. PLoS ONE 2014;9:e91781.
44. Gray AM, Clarke PM, Wolstenholme JL, et al. Applied methods of
cost-effectiveness analysis in healthcare (handbooks in health
economic evaluation). Oxford: Oxford University Press, 2011.
45. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the
role of cost-effectiveness acceptability curves. Health Econ
2001;10:779–87.
46. Tan-Torres Edejer T, Baltussen R, Adam T, et al. Making choices in
health: WHO guide to cost-effectiveness analysis. Geneva: World
Health Organization, 2003.
47. Tandon A, Cashin C. Assessing public expenditure on health from a
fiscal space perspective. Washington DC: The World Bank, 2010.
48. Heller PS. The prospects of creating ‘fiscal space’ for the health
sector. Health Policy Plan 2006;21:75–9.
49. Briggs A. Probabilistic analysis of cost-effectiveness models:
statistical representation of parameter uncertainty. Value Health
2005;8:1–2.
50. Baltussen R, Niessen L. Priority setting of health interventions: the need
for multi-criteria decision analysis. Cost Eff Resour Alloc 2006;4:14.
8 Skordis-Worrall J, et al. BMJ Open 2016;6:e012046. doi:10.1136/bmjopen-2016-012046
Open Access
group.bmj.com on December 12, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
India (CARING trial)
growth among children under two in rural
community-based intervention to improve 
Protocol for the economic evaluation of a
Hassan Haghparast-Bidgoli
Anthony Costello, Andrew Copas, Naomi Saville, Audrey Prost and
Aradhana Srivastava, Neha Batura, Anni-Maria Pulkki-Brännström, 
Bhattacharyya, Rajkumar Gope, Shibanand Rath, Suchitra Rath,
Sarangi, Nirmala Nair, Prasanta Tripathy, H S Sachdev, Sanghita 
Jolene Skordis-Worrall, Rajesh Sinha, Amit Kumar Ojha, Soumendra
doi: 10.1136/bmjopen-2016-012046
2016 6: BMJ Open 
 http://bmjopen.bmj.com/content/6/11/e012046
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/6/11/e012046
This article cites 35 articles, 8 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by/4.0/
use, provided the original work is properly cited. See: 
others to distribute, remix, adapt and build upon this work, for commercial
the Creative Commons Attribution (CC BY 4.0) license, which permits 
This is an Open Access article distributed in accordance with the terms of
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (522)Research methods
 (529)Paediatrics
 (287)Nutrition and metabolism
 (292)Health economics
 (385)Global health
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on December 12, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
